StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) income statement

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.03+0.05 (+1.68%)

Close on Nov 20, 2026Market cap $112.66MP/E –Yield –

Armata Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?